Clinical Trial Update: Brodalumab in Palmoplantar Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for brodalumab in palmoplantar psoriasis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Palmoplantar Psoriasis

Drugs mentioned

• brodalumab (brodalumab)

Snippet

Sponsor: First OC Dermatology | Conditions: Palmoplantar Psoriasis | Phase 4 | Status: UNKNOWN